A Study of BIBW 2992 (Afatinib) in Patients With Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Cetuximab
Related studies linked through entity extraction aliases.
An Observational Study to Evaluate the Safety and Efficacy of Cetuximab in Combination With Platinum-based Chemotherapy in the First-line Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck
- Status
- TERMINATED
- Phase
- N/A
An Observational Study to Evaluate the Safety and Efficacy of FOLFIRI / FOLFOX Plus Cetuximab as First-line Therapy in Patients With KRAS Wild-type Metastatic Colorectal Cancer
- Status
- TERMINATED
- Phase
- N/A
Lenalidomide and Cetuximab in Treating Patients With Metastatic Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Safety Study of Cetuximab in Combination With Cisplatin and Vinorelbine to Treat Advanced Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Radiation Therapy and Chemotherapy, With or Without Cetuximab, Followed by Surgery in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed by Surgery
- Status
- COMPLETED
- Phase
- PHASE3
Re-irradiation With Fractionated Stereotactic Radiosurgery Plus Cetuximab in Patients With Recurrent Squamous Cell Carcinoma of the Head and Neck
- Status
- COMPLETED
- Phase
- PHASE2
Study in Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Neo-Adjuvant Study in Triple Negative Breast Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE2
Trial of BIBW 2992 (Afatinib) + Cetuximab in Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Study for Participants With Recurrent or Metastatic Squamous Cell Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Efficacy Study of BMS-908662 Alone or in Combination With Cetuximab in Subjects With K-RAS or B-RAF Mutation Positive Advanced or Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Induction Chemotherapy Followed By Cetuximab and Radiation in HPV-Associated Resectable Stage III/IV Oropharynx Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study in Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Irinotecan Hydrochloride and Cetuximab With or Without Ramucirumab in Treating Patients With Advanced Colorectal Cancer With Progressive Disease After Treatment With Bevacizumab-Containing Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE2
Everolimus, Cetuximab and Capecitabine in Patients With Metastatic Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Post-marketing Surveillance Study on Erbitux in Combination With Platinum-based Chemotherapy in Metastatic/Recurrent Squamous Cell Cancer of the Head and Neck
- Status
- WITHDRAWN
- Phase
- N/A
Prospective, Post Marketing Surveillance Study On Erbitux® (Cetuximab) in Patients With Locally Advanced or Recurrent and/or Metastatic Squamous Cell Cancer of the Head and Neck in Korea
- Status
- COMPLETED
- Phase
- N/A
ARQ 197 in Combination With Chemotherapy in Patients With Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
An Observational Study of Erbitux® in Patients With Metastatic Colorectal Cancer (mCRC) Refractory to Irinotecan-containing Treatment
- Status
- TERMINATED
- Phase
- N/A